Clinical trials data
Picture Naming Test in dementia and Alzheimer's trials: 104 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names the Picture Naming Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 104
- Name it in a primary outcome, 37%
- 38 of 104
Tests named in the same studies
- 1
Trail Making Test50 studies, 20 as a primary outcome
- 2
Verbal Learning47 studies, 23 as a primary outcome
- 3
Verbal Fluency45 studies, 19 as a primary outcome
- 4
Digit Span Test44 studies, 15 as a primary outcome
- 5
Category Fluency39 studies, 13 as a primary outcome
- 6
Short Story Recall24 studies, 11 as a primary outcome
- 7
Clock Drawing Task22 studies, 8 as a primary outcome
- 8
Complex Figure Copy and Recall15 studies, 9 as a primary outcome
- 9
Symbol Coding14 studies, 10 as a primary outcome
- 10
Stroop Color-Word Test13 studies, 9 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 3 | 1 |
| 2011 | 3 | 3 |
| 2012 | 3 | 1 |
| 2013 | 2 | 1 |
| 2014 | 2 | 0 |
| 2015 | 5 | 2 |
| 2016 | 2 | 1 |
| 2017 | 6 | 1 |
| 2018 | 6 | 4 |
| 2019 | 6 | 1 |
| 2020 | 6 | 1 |
| 2021 | 8 | 3 |
| 2022 | 11 | 4 |
| 2023 | 10 | 4 |
| 2024 | 9 | 5 |
| 2025 | 10 | 1 |
| 2026 | 8 | 3 |
Phases and study sizes
By phase
- Early phase 13 studies, 0 as a primary outcome
- Phase 14 studies, 1 as a primary outcome
- Phase 1/23 studies, 0 as a primary outcome
- Phase 212 studies, 5 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable50 studies, 20 as a primary outcome
- Observational27 studies, 11 as a primary outcome
Participants per study
- Phase 248 median, 24 to 93
- Not applicable60 median, 40 to 112
- Observational550 median, 168 to 1,650
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 12 | 48 | 24 to 93 |
| Not applicable | 50 | 60 | 40 to 112 |
| Observational | 27 | 550 | 168 to 1,650 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day8 outcomes, 4 as a primary outcome
- Up to 4 weeks5 outcomes, 2 as a primary outcome
- 1 to 3 months27 outcomes, 13 as a primary outcome
- 3 to 6 months19 outcomes, 5 as a primary outcome
- 6 to 12 months18 outcomes, 3 as a primary outcome
- 1 to 2 years8 outcomes, 1 as a primary outcome
- Over 2 years16 outcomes, 8 as a primary outcome
- No duration given3 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
101 of the 104 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting21 studies, 6 as a primary outcome
- Not yet recruiting11 studies, 3 as a primary outcome
- Active, not recruiting5 studies, 1 as a primary outcome
- Completed39 studies, 15 as a primary outcome
- Stopped early10 studies, 5 as a primary outcome
- Status unknown18 studies, 8 as a primary outcome
What they test
- Behavioral26 studies, 13 as a primary outcome
- Drug22 studies, 6 as a primary outcome
- Device20 studies, 7 as a primary outcome
- Dietary supplement4 studies, 2 as a primary outcome
- Procedure4 studies, 2 as a primary outcome
- Diagnostic test1 studies, 0 as a primary outcome
- Biological4 studies, 0 as a primary outcome
- Radiation2 studies, 1 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other21 studies, 7 as a primary outcome
- None given17 studies, 7 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States40 studies, 15 as a primary outcome
- China24 studies, 7 as a primary outcome
- Spain12 studies, 5 as a primary outcome
- Canada9 studies, 1 as a primary outcome
- France8 studies, 2 as a primary outcome
- Italy7 studies, 3 as a primary outcome
- United Kingdom7 studies, 1 as a primary outcome
- Belgium6 studies, 1 as a primary outcome
- Netherlands6 studies, 1 as a primary outcome
- Australia5 studies, 0 as a primary outcome
- Sweden5 studies, 1 as a primary outcome
- Germany3 studies, 0 as a primary outcome
30 countries in all. A study with sites in several counts in each; 6 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name the Picture Naming Test: 28 of 39, 72%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name the Picture Naming Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 7, 18% | 776, 10% |
| Results on ClinicalTrials.gov only | 6, 15% | 1,139, 14% |
| A results paper only | 15, 38% | 1,711, 22% |
| Neither | 11, 28% | 4,327, 54% |
The 104 studies
104 studies match. 38 name the Picture Naming Test in a primary outcome. Median size 83 participants. Median time to the primary outcome: 13 weeks.
Loading 104 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 3 | 1 |
| 2011 | 3 | 3 |
| 2012 | 3 | 1 |
| 2013 | 2 | 1 |
| 2014 | 2 | 0 |
| 2015 | 5 | 2 |
| 2016 | 2 | 1 |
| 2017 | 6 | 1 |
| 2018 | 6 | 4 |
| 2019 | 6 | 1 |
| 2020 | 6 | 1 |
| 2021 | 8 | 3 |
| 2022 | 11 | 4 |
| 2023 | 10 | 4 |
| 2024 | 9 | 5 |
| 2025 | 10 | 1 |
| 2026 | 8 | 3 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 8, other 96. Interventional 77, observational 27.
As a primary outcomeSecondary or other outcomeThe Picture Naming Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07722169 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07638813 | Start2026 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants33 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07509125 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Parkinson's disease, Schizophrenia and psychosis, Sleep and sleep disorders | Participants300 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07402356 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Depression and bipolar disorder | Participants140 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07314190 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Parkinson's disease, Schizophrenia and psychosis, Depression and bipolar disorder | Participants1,799 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07239843 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Parkinson's disease, Schizophrenia and psychosis, Depression and bipolar disorder | Participants1,310 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07230158 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants160 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07214974 | Start2026 | PhaseEarly phase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease | Participants600 | Lead sponsorIndustry | StatusNot yet recruiting | Library tests named
|
| NCT07210528 | Start2025 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants48 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07154485 | Start2025 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants15 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07109999 | Start2019 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants2,835 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07031687 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06946511 | Start2025 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06883019 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants114 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06775964 | Start2026 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants12 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06761729 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants3 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06756828 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06739967 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06595511 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06452147 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Delirium, surgery and intensive care | Participants1,860 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06419101 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants3,000 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06380725 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use the Picture Naming Test?
104 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 38 of them in a primary outcome: 6% of the condition's 1,673 studies with a cognitive outcome, against 3% of all of them. It is the 8th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with the Picture Naming Test?
The Trail Making Test (50 studies), Verbal Learning (47 studies) and Verbal Fluency (45 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use the Picture Naming Test enroll?
Half of the phase 2 studies that name it enroll 48 participants or fewer, and the middle half enroll 24 to 93. 12 of them give a size.
When do dementia and Alzheimer's trials measure the Picture Naming Test?
Half of the primary outcomes that name the Picture Naming Test are measured within 13 weeks of the start, and the middle half from 9 weeks to 13 months. 36 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use the Picture Naming Test have reported results?
28 of the 39 completed studies that name it, 72%, have reported results: 13 posted them on ClinicalTrials.gov, 22 have a results paper linked to the registry record, and 7 did both. The other 11 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Picture Naming Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.